Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued to investors on Wednesday morning. The firm issued a hold rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and issued a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

MLSS opened at $1.27 on Wednesday. Milestone Scientific has a 1 year low of $0.54 and a 1 year high of $1.39. The business’s 50-day moving average is $0.98 and its two-hundred day moving average is $0.93. The firm has a market capitalization of $98.92 million, a PE ratio of -18.14 and a beta of 1.10.

Hedge Funds Weigh In On Milestone Scientific

Large investors have recently made changes to their positions in the business. Carnegie Investment Counsel lifted its stake in shares of Milestone Scientific by 18.9% in the fourth quarter. Carnegie Investment Counsel now owns 172,609 shares of the company’s stock worth $166,000 after buying an additional 27,412 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific during the 3rd quarter worth $48,000. Finally, World Investment Advisors LLC acquired a new stake in Milestone Scientific during the 3rd quarter worth $91,000. Institutional investors and hedge funds own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.